Literature DB >> 23225202

Inflammation is associated with the remodeling of calcific aortic valve disease.

Nancy Coté1, Ablajan Mahmut, Yohan Bosse, Christian Couture, Sylvain Pagé, Sylvain Trahan, Marie-Chloé Boulanger, Dominique Fournier, Philippe Pibarot, Patrick Mathieu.   

Abstract

Calcific aortic valve disease (CAVD) is the most frequent heart valve disorder. Studies indicate that mineralization of the aortic valve may be related to the inflammatory process. However, no clear evidence has been given regarding clinical evolution of aortic stenosis and the inflammatory process within the aortic valve. Aortic valves excised from 285 patients with CAVD undergoing aortic valve replacement were analyzed for the presence of chronic inflammatory infiltrates, and those findings were related to the hemodynamic severity of aortic stenosis. In a subset of 57 patients, in whom additional valvular tissue and the clinical progression rate of aortic stenosis were available, the density of leukocytes was determined as well as the number of TNF-α transcripts. Histological analyses revealed that in 81 (28.4 %) patients, the presence of chronic inflammatory infiltrates was documented within CAVD tissue, which was characterized by the existence of a cluster of cells as well as the presence of neovascularisation and osseous metaplasia. The presence of an inflammatory process within the CAVD tissue was independently related to the remodeling process and the peak transaortic gradient. In addition, the density of leukocytes within CAVD tended to correlate (r = 0.25, p = 0.05) with the progression rate of aortic stenosis. Dense inflammatory infiltrate within CAVD is associated with an active remodeling process, the severity of aortic stenosis, and the hemodynamic progression rate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23225202     DOI: 10.1007/s10753-012-9579-6

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  22 in total

1.  Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography.

Authors:  David Messika-Zeitoun; Marie-Christine Aubry; Delphine Detaint; Lawrence F Bielak; Patricia A Peyser; Patrick F Sheedy; Stephen T Turner; Jerome F Breen; Christopher Scott; A Jamil Tajik; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2004-07-12       Impact factor: 29.690

2.  Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis.

Authors:  Martin Briand; Isabelle Lemieux; Jean G Dumesnil; Patrick Mathieu; Amélie Cartier; Jean-Pierre Després; Marie Arsenault; Jacques Couet; Philippe Pibarot
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

Review 3.  Obesity, inflammation, and cardiovascular risk.

Authors:  P Mathieu; I Lemieux; J-P Després
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

4.  Bone formation and inflammation in cardiac valves.

Authors:  E R Mohler; F Gannon; C Reynolds; R Zimmerman; M G Keane; F S Kaplan
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

5.  Distribution of SPARC during neovascularisation of degenerative aortic stenosis.

Authors:  A Charest; A Pépin; R Shetty; C Côté; P Voisine; F Dagenais; P Pibarot; P Mathieu
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

6.  Calcification of the aortic valve: its progression and grading.

Authors:  B A Warren; J L Yong
Journal:  Pathology       Date:  1997-11       Impact factor: 5.306

7.  Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.

Authors:  Dania Mohty; Philippe Pibarot; Jean-Pierre Després; Claude Côté; Benoit Arsenault; Amélie Cartier; Pierre Cosnay; Christian Couture; Patrick Mathieu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-01       Impact factor: 8.311

8.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

9.  Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.

Authors:  C Côté; P Pibarot; J-P Després; D Mohty; A Cartier; B J Arsenault; C Couture; P Mathieu
Journal:  Heart       Date:  2007-10-11       Impact factor: 5.994

10.  Mast cells in human stenotic aortic valves are associated with the severity of stenosis.

Authors:  E Wypasek; J Natorska; G Grudzień; G Filip; J Sadowski; A Undas
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

View more
  64 in total

1.  MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling.

Authors:  Dongdong Zheng; Yue Zang; Haixia Xu; Yan Wang; Xiang Cao; Teng Wang; Min Pan; Jiahai Shi; Xiaofei Li
Journal:  Clin Res Cardiol       Date:  2018-12-05       Impact factor: 5.460

2.  Graded murine wire-induced aortic valve stenosis model mimics human functional and morphological disease phenotype.

Authors:  Sven Thomas Niepmann; Eva Steffen; Andreas Zietzer; Matti Adam; Julia Nordsiek; Isabella Gyamfi-Poku; Kerstin Piayda; Jan-Malte Sinning; Stephan Baldus; Malte Kelm; Georg Nickenig; Sebastian Zimmer; Christine Quast
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

3.  RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing.

Authors:  Sandra Guauque-Olarte; Arnaud Droit; Joël Tremblay-Marchand; Nathalie Gaudreault; Dimitri Kalavrouziotis; Francois Dagenais; Jonathan G Seidman; Simon C Body; Philippe Pibarot; Patrick Mathieu; Yohan Bossé
Journal:  Physiol Genomics       Date:  2016-08-05       Impact factor: 3.107

4.  Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure.

Authors:  Hiroki Matsumoto; Takatoshi Kasai; Akihiro Sato; Sayaki Ishiwata; Shoichiro Yatsu; Jun Shitara; Azusa Murata; Takao Kato; Shoko Suda; Yuya Matsue; Masaru Hiki; Atsutoshi Takagi; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2019-05-18       Impact factor: 2.037

5.  Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease.

Authors:  Ana M Porras; Jennifer A Westlund; Austin D Evans; Kristyn S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

6.  Protective Role of Smad6 in Inflammation-Induced Valvular Cell Calcification.

Authors:  Xin Li; Jina Lim; Jinxiu Lu; Taylor M Pedego; Linda Demer; Yin Tintut
Journal:  J Cell Biochem       Date:  2015-10       Impact factor: 4.429

7.  Macrophages Promote Aortic Valve Cell Calcification and Alter STAT3 Splicing.

Authors:  Michael A Raddatz; Tessa Huffstater; Matthew R Bersi; Bradley I Reinfeld; Matthew Z Madden; Sabrina E Booton; W Kimryn Rathmell; Jeffrey C Rathmell; Brian R Lindman; Meena S Madhur; W David Merryman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-16       Impact factor: 8.311

Review 8.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

9.  Secreted Factors From Proinflammatory Macrophages Promote an Osteoblast-Like Phenotype in Valvular Interstitial Cells.

Authors:  Joseph C Grim; Brian A Aguado; Brandon J Vogt; Dilara Batan; Cassidy L Andrichik; Megan E Schroeder; Andrea Gonzalez-Rodriguez; F Max Yavitt; Robert M Weiss; Kristi S Anseth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-17       Impact factor: 8.311

Review 10.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.